Luther King Capital Management (LKCM)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $508K | Buy |
|
|||||
|
2025
Q2 | $435K | Buy |
|
|||||
|
2025
Q1 | $525K | Hold |
|
|||||
|
2024
Q4 | $590K | Sell |
|
|||||
|
2024
Q3 | $885K | Buy |
|
|||||
|
2024
Q2 | $873K | Buy |
|
|||||
|
2024
Q1 | $797K | Hold |
|
|||||
|
2023
Q4 | $727K | Hold |
|
|||||
|
2023
Q3 | $681K | Hold |
|
|||||
|
2023
Q2 | $595K | Sell |
|
|||||
|
2023
Q1 | $703K | Sell |
|
|||||
|
2022
Q4 | $815K | Sell |
|
|||||
|
2022
Q3 | $829K | Sell |
|
|||||
|
2022
Q2 | $1.07M | Buy |
|
|||||
|
2022
Q1 | $1.16M | Hold |
|
|||||
|
2021
Q4 | $1.04M | Sell |
|
|||||
|
2021
Q3 | $1.13M | Hold |
|
|||||
|
2021
Q2 | $1.04M | Buy |
|
|||||
|
2021
Q1 | $203K | Hold |
|
|||||
|
2020
Q4 | $207K | Sell |
|
|||||
|
2020
Q3 | $297K | Buy |
|
|||||
|
2020
Q2 | $311K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $310K | Hold |
|
|||||
|
2017
Q3 | $369K | Buy |
|
|||||
|
2017
Q2 | $334K | Sell |
|
|||||
|
2017
Q1 | $283K | Sell |
|
|||||
|
2016
Q4 | $376K | Sell |
|
|||||
|
2016
Q3 | $563K | Sell |
|
|||||
|
2016
Q2 | $513K | Buy |
|
|||||
|
2016
Q1 | $479K | Buy |
|
|||||
|
2015
Q4 | $532K | Sell |
|
|||||
|
2015
Q3 | $558K | Sell |
|
|||||
|
2015
Q2 | $694K | Buy |
|
|||||
|
2015
Q1 | $603K | Sell |
|
|||||
|
2014
Q4 | $593K | Hold |
|
|||||
|
2014
Q3 | $521K | Buy |
|
|||||
|
2014
Q2 | $330K | Buy |
|
|||||
|
2014
Q1 | $270K | Buy |
|